How I Read Hints to NIH Grant Writers from NIH Director on Emerging Funding Priorities

Have your study design experts write to me to discuss any of this if they do not fully understand how to operationalize these priorities and reform science.

The Epistemic Realignment of NIH

Jay Bhattacharya’s appointment as Director of the National Institutes of Health marks a radical epistemological shift. His approach, revealed through interviews in Reason Magazine (August 2, 2025) and Paul D. Thacker’s Disinformation Chronicle (July 22, 2025), Jay explains how NIH has now moved away from bureaucratic orthodoxy and into a new regime of scientific pluralism (within reason), dissent tolerance, and method-based integrity. Researchers seeking NIH support will do well now internalize a new rulebook: proposals should center not on conformity to past consensus, but on the integrity of epistemic process, the clarity of mechanistic hypothesis, and the willingness to investigate scientific uncertainty without fear of professional exile.

Proposals should reflect these priorities not only in aim but in structure, budget, and operational design. Scientific dissent, replication studies, red-teaming, and data transparency should no longer be peripheral values—they should explicit, straightforward, and budgeted. They should be embedded, hallmark features of your proposals. Below, I interpret how Bhattacharya’s explicit signals convey how to approach grantsmanship, and how to translate them into actionable, fundable components of NIH proposals.

Epistemic Decentralization and Institutional Feedback

Bhattacharya has committed to protecting good-faith dissent inside the NIH itself. His engagement with critics of NIH policy, including the authors of the Bethesda Declaration, marks a shift from narrative consolidation to pluralistic governance. He has publicly stated, "Why would I retaliate against colleagues who, though I disagree with them … care very deeply about the NIH and want the NIH to succeed?"

Researchers should now understand that NIH is no longer looking for passive alignment but for proposals that demonstrate reflexivity and resilience. It is essential to build red-teaming structures into the project’s operational plan—explicit subgroups or external advisory panels tasked with challenging the project’s assumptions and analytic models. This is not an optional activity. These mechanisms should be formally included in the structure of the proposal and explicitly budgeted as line items in personnel or consulting.

Reproducibility, Constructive Failure, and Open Science

Bhattacharya has emphasized that objective science accommodates failure as learning without stigmatization. He remarked, "We punish failure too much in science," highlighting the need for research culture that understands null results and replication as part of scientific method.

Grant proposals would do very well now include planned reproducibility components. These include internal replication arms, where a defined percentage of the study sample is analyzed independently; formal preregistration of hypotheses and statistical pipelines; and budgets for reporting negative or null findings. These reproducibility elements should appear not as narrative aspirations, but as components built into explicit study aims, titled sections, data analysis plans, and budgeted project phases. NIH is not funding rhetorical commitments to transparency—it is funding operationalized transparency.

Data sharing and open publication plans should be well-done and formalized. Researchers should consider using thematic conceptual infrastructures such as IP2H (Integrative Pathways to Health) and IP2MH (Mental Health) for bringing in integrative medicine and therapies to study in combination to optimize process protocols. They should publish beyond the paywalls of the "Big Six" journal conglomerates.

Use of intelligent methods optimization (IMO) to select methods that generate generalizable results is a smart way to avoid confirmation bias prone repeated rounds of data analysis. Experts in machine learning can set this up and it yields maximally defensible results without arbitrary model selection. Send your machine learning and biostats people my way to learn more; it was the secret to our success at The University of Pittsburgh in the Bioinformatics Analysis Core where, over ten years we held >300 meetings and designed studies leading to >100 sets of results: Accept that different methods of analysis yield different results, and then, transparently optimize the selection of the final results on reproducibility and generalizability.

Do NOT select the result that supports your pet hypothesis or enforces your narrative.

Formalized Use Strategic Dissent and the End of "Me Too" Science

"Groupthink is a real danger in science," Bhattacharya warned, criticizing the dominant trend of thematic mimicry that props up dominant paradigms with minimal mechanistic challenge. NIH will no longer reward conformity. Rather, it will reward intellectual courage paired with methodological discipline.

To that end, proposals should include competitive hypothesis models. Pragmatic trials of combinations of therapy options fit this model. Rather than testing a single favored pathway, include an alternative model with its own mechanistic justification and a plan for adjudicating between them. Better yet, build in a red-teaming unit or consultant with the authority and budget to pressure-test the core assumptions of your study. You know, rational discourse. That thing where we agree for the sake of a cup of coffee, but we disagree for the sake of tempering the steel of our comprehension.

This, again, should be structural. Include red-teaming protocols as a distinct work package. Name the participants or how they will selected. Allocate person-months. Budget for dissent. Make subjective weights on evidence transparent, and consistent with their bona fide merit.

Precision Biology and Autism Research Redefined

Bhattacharya’s Autism Data Science Initiative represents a new direction in neurodevelopmental science. He explicitly noted that "Calling it a disorder is wrong for many parts of the spectrum," and has pushed NIH to differentiate the spectrum according to biological subtype, mechanistic etiology, and co-occurring system dysfunctions.

Proposals in autism research should now stratify or otherwise directly address differences among subjects beyond exclusion criteria. Include multi-omic phenotyping to understand risk stratification. Segment groups by genotype, immune markers, GI pathology, mitochondrial profiles, or neuroinflammatory load. Not to “adjust for” these; those days are long gone. But to address them head-on as risk co-factors with environmental exposures, like vaccines, or to study earnestly different characteristics of subgroups, or to map pathways to health that may vary depending on subgroups. At a minimum, escribe your analytic strategy for handling heterogeneity. Budget for subgroup-specific analyses, additional sequencing, or computational modeling. Use my Integrative Pathways to Mental Health IP2MH infrastructure where applicable for the formal assessment and comparison of open-label treatments and therapies. Again, send your people my way if you do not know what that is.

Environmental Health and Local Exposure Studies

In response to inquiries about NIH's climate-related priorities, Bhattacharya clarified that NIH is focused on health impacts of environmental exposures, not on CO2 modeling. He highlighted NIH-funded research into the East Palestine ecological disaster as an example.

Researchers should now focus on human health outcomes of discrete environmental exposures. Study designs should be be geotagged and heterogeneity aware, not streamlined to remove clinical outliers. Recruit from affected communities. Include at-risk community engagement plans and offer feedback reports to participants. Budget for these activities.

Mechanistic Frameworks to End Chronic Illness

Bhattacharya's agenda includes dismantling NIH's complacency around chronic disease management. He has explicitly prioritized prevention and resolution over treatment and maintenance. Proposals in this space should use systems-level modeling.

Propose mechanistic investigations into causality: neuroinflammation, mitochondrial dysfunction, immune dysregulation, redox imbalance, or endocrine disruption. Include longitudinal cohort components where feasible. Offer a mechanistic hypothesis for chronic disease persistence and describe how your design will test it. If your project uses trait matrices, tackles complexity, and genetic context for environmental exposures - even common, ones that were formerly taboo - make that clear. These are not fringe anymore—they are frontier.

Publishing Reform and Public Trust

Bhattacharya has vocally criticized the scientific publishing establishment, stating, "The people that control the journals, in particular the editors, often have an interest in promoting a narrative."

NIH under his leadership is moving toward capping article processing charges and encouraging publication outside the legacy journal system. Proposals should include dissemination plans that incorporate:

• Preprint posting timelines

• Open data repositories

• Translation plans for lay and community audiences

• Budgets for open-access dissemination

Include your publishing strategy in the budget justification section and make clear you do not intend to bury null results or controversial findings behind paywalls.

Translating Vision into Structure

These are not abstract principles. For success, every one of Bhattacharya’s stated priorities should be transposed into the design, structure, and budget of the grant proposal. Not simply as aspirations, but as logistical blueprints.

A project that supports dissent must budget for dissent. A project committed to reproducibility must pay for replication. A project addressing environmental exposure must allocate funds to local engagement. A chronic illness proposal must have a named mechanistic model with an evaluation strategy and an eye on Prediction, Prevention, Mitigation, Treatment and Reversal. Publishing plans must show how the public will access your findings, including the time-stamped data analysis plan and the raw, unfiltered early-stage data.

NIH is no longer tolerating token compliance. It is funding intellectual integrity, and it expects to see the scaffolding for that integrity written into every section of your application.

Conclusion: From Compliance to Coherence

This is not a call for rebellion. It is a call for rigor. Jay Bhattacharya's NIH is re-engineering the incentive structure to reward researchers who build self-correcting systems, who defend the possibility of being wrong, and who pursue truth over tenure.

The next generation of funded science will not be an echo chamber. It will be a self-auditing network of thinkers, designers, dissenters, and builders. If your proposal can show that it belongs to that future, the NIH will fund it. Not because it agrees with you, but because it trusts your process.